Tenecteplase no longer 'off label' for acute ischemic stroke
UC expert featured in MedCentral article
The University of Cincinnati's Yasmin Aziz was featured in a MedCentral article discussing the recent FDA approval of the drug tenecteplase (TNK) for treatment of acute ischemic stroke.
Trials of alteplase, also called tPA, were pioneered at the University of Cincinnati in the late 1980s, representing the first proven treatment for ischemic stroke. TNK is a more recently developed clot-busting drug that can be administered in a single IV injection within seconds.
Aziz said many academic health centers and private institutions have been using TNK off label since data from the 2022 ACT trial was published.
While there are new dosing instructions associated with the FDA approval, Aziz said the speed of delivering TNK makes it appealing. Administering tPA requires a 1-minute infusion followed by a 60-minute infusion of the rest of the dosage, while TNK requires a 5-second infusion.
“I will tell you, the ease of use is really what’s going to get people to change," said Aziz, MD, director, Acute Stroke Trials; associate director, Vascular Neurology Fellowship; and assistant professor in the Department of Neurology and Rehabilitation Medicine in UC's College of Medicine; UC Health neurologist; director, NIH StrokeNet Digital Media; and co-investigator, NIH StrokeNet Ohio Valley Regional Coordinating Center.
“I think this will hopefully allow us to treat more patients faster with less chance of error,” she continued. “It’s much easier to give a drug like tenecteplase in a moving ambulance."
Featured photo at top of illustration of brain with stroke symptoms. Photo/PeterSchreiber.media/iStock.
Related Stories
University of Cincinnati’s IDD Education Center to Host Ninth Annual Red & Black Blast
December 18, 2025
The University of Cincinnati’s IDD Education Center will host its ninth annual Red & Black Blast on February 25, 2026, at Tangeman University Center. The signature event celebrates and supports the Center’s four programs—CEES, TAP, IMPACT Innovation, and RAAC—which create pathways in education, employment, and community life for individuals with intellectual and developmental disabilities (IDD).
Ohio looks to fast-track wastewater discharge permits
December 16, 2025
Bradford Mank, James B. Helmer Jr. Professor of Law at the University of Cincinnati, spoke with WVXU for a story about a proposal by the Ohio Environmental Protection Agency to streamline the way wastewater discharge permits are issued to data centers.
Tariff troubles for online shoppers
December 16, 2025
This year’s new regulations on tariffs and customs are leaving holiday shoppers with unexpected fees on some of their purchases, according to recent reporting by WLWT. Associate Dean of Impact and Partnerships for the University of Cincinnati’s Lindner College of Business Charles Sox spoke to WLWT about why shoppers are only just now feeling the impact, despite these policies being in effect for months.